Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2016 | 2020 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.330 | None | 1.000 | 3 | 0 | 2016 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.320 | None | 1.000 | 2 | 2 | 2008 | 2020 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
group | 0.100 | None | 0.960 | 25 | 0 | 2008 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
group | 0.100 | None | 0.933 | 15 | 0 | 2003 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2003 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
phenotype | 0.080 | None | 1.000 | 8 | 0 | 2008 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2009 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2018 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2009 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2018 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2010 | 2018 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
group | 0.050 | None | 1.000 | 5 | 0 | 2014 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2016 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2020 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2016 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2009 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2014 | 2019 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 2009 | 2015 | ||||||||
|
activating transcription factor 4 | 0.507 | 0.769 | 1.6E-02 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2017 | 2019 |